Calophyllum brasiliense Cambess (Clusiaseae) is a variety that is secondhand in the timber industry accompanying applications in reforestation and soil improvement, in addition to allure potential use in folk medicine. C. brasiliense is an evergreen shrub species owned by the tropical rainforest that evolves from Brazil to Mexico. C. brasiliense is an alternative source in traditional cure to make antagonistic-inflammatory patches, remedies to treat various afflictions such as gastrointestinal, diabetes and skin afflictions. C. brasiliense biosynthesizes calanolides and inophyllum compounds that can inhibit human immunodeficiency bug type 1 (HIV-1) reverse transcriptase. It is worth noting the compound (+)-calanolide A, that is a drug of natural inception approved for one FDA for the treatment of HIV/AIDS. C. brasiliense produces other compounds in the way that coumarins, chromanones, xanthones, and mammea-type triterpenes, which demonstrated antitumor, antiparasitic, antibacterial, and antispasmodic action. C. brasiliense produces secondary metabolites that are found in very depressed concentrations (<1%), which is a loss. To increase the production of extreme-value phytochemicals such as calanolides, it should to explore effective methods and the use of biotechnological finishes such as plant cell educations for the efficient result of phytochemicals in a sustainable manner. The objective concerning this review is to specify essential information on C. brasiliense, allure traditional uses, and its phytochemical elements.
Author(s) Details:
A. Bernabé-Antonio,
A. Bernabé-Antonio
L.
P. Álvarez-Berber,
Chemical
Research Center-IICBA, Autonomous University of the State of Morelos, Av.
Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Morelos, Mexico.
F. Cruz-Sosa,
Department of Biotechnology, Division of Biological and Health Sciences,
Metropolitan Autonomous University-Iztapalapa Campus, 186 Ferrocarril de San
Rafael Atlixco, CDMX-09340, México.
Please see the link here: https://stm.bookpi.org/CERB-V7/article/view/10492
No comments:
Post a Comment